Search Results

A comparison study of temporal trends of SARS-CoV2 RNAemia and biomarkers to predict success and failure of high flow oxygen therapy among patients with moderate to severe COVID-19.

• Authors : Koyama H; Department of Critical Care Medicine, Shonan Kamakura General Hospital, Kamakura, Japan.; Sakai K

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/virology

• Source: PloS one [PLoS One] 2024 Jul 10; Vol. 19 (7), pp. e0305077. Date of Electronic Publication: 2024 Jul 10 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy.

• Authors : Katagiri D; Department of Nephrology, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.; Tsukada A

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Polymyxin B*/Polymyxin B*/Polymyxin B*/administration & dosage ; Polymyxin B*/Polymyxin B*/Polymyxin B*/therapeutic use

• Source: Scientific reports [Sci Rep] 2024 May 31; Vol. 14 (1), pp. 12550. Date of Electronic Publication: 2024 May 31.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Effectiveness of hyperbaric oxygen therapy in the management of COVID-19-associated mucormycosis.

• Authors : Pandey S; Department of Plastic Surgery, King George's Medical University, Lucknow, India.; Kumar V

Subjects: Mucormycosis*/Mucormycosis*/Mucormycosis*/therapy ; Hyperbaric Oxygenation* ; COVID-19*/COVID-19*/COVID-19*/therapy

• Source: Medical gas research [Med Gas Res] 2024 Apr-Jun; Vol. 14 (2), pp. 87-88.Publisher: STM Publishing Country of Publication: Australia NLM ID: 101564536 Publication Model: Print Cited Medium: Internet ISSN: 2045-9912

Record details

Comparison of ROX, HROX, and delta-HR indices to predict successful weaning from high-flow oxygen therapy in hospitalized patients with COVID-19 pneumonia.

• Authors : Ruchiwit P; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Thammasat University, Klongluang, Pathum Thani, Thailand.; Madua J

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Respiratory Insufficiency*/Respiratory Insufficiency*/Respiratory Insufficiency*/therapy ; Noninvasive Ventilation*

• Source: PloS one [PLoS One] 2024 Feb 15; Vol. 19 (2), pp. e0297624. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

High plasma soluble CLEC-2 level predicts oxygen therapy requirement in patients with COVID-19.

• Authors : Oishi S; Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.; Department of Laboratory, University of Yamanashi Hospital, Yamanashi, Japan.

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Cell-Free Nucleic Acids*; Humans

• Source: Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2244594. Date of Electronic Publication: 2023 Aug 14.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9208117 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

High-flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS-CoV-2 pneumonia out of ICU.

• Authors : Castro S; Pneumology Service, Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain.; Department of Medicine and Surgery, Facultad de Medicina y Enfermería, Universidad del País Vasco/Euskal Herriko Unibertsitatea UPV/EHU, Leioa, Bizkaia, Spain.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/therapy ; Pneumonia*/Pneumonia*/Pneumonia*/therapy

• Source: The clinical respiratory journal [Clin Respir J] 2023 Sep; Vol. 17 (9), pp. 905-914. Date of Electronic Publication: 2023 Aug 04.Publisher: Blackwell Publishing Country of Publication: England NLM ID: 101315570 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Sequential Oxygen Therapy in COVID-19 Diabetic Patients: A Retrospective Cohort Study.

• Authors : SURYAWANSHI, CHHAYA M.¹; MAHANTA, DIPANJALI²

• Source: Journal of Clinical & Diagnostic Research. Mar2024, Vol. 18 Issue 3, p10-13. 4p.

Record details

Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study.

• Authors : Zeng Y; Department of Respiratory and Critical Care Medicine, Fifth People's Hospital of Shanghai, Fudan University, 801 Heqing Road, Shanghai, 200240, China.; Center of Community-Based Health Research, Fudan University, Shanghai, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy; Humans ; Case-Control Studies

• Source: BMC infectious diseases [BMC Infect Dis] 2023 Jun 29; Vol. 23 (1), pp. 440. Date of Electronic Publication: 2023 Jun 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Effect of Hyperbaric Oxygen Therapy on Patients with SARS-CoV-2 Infection: A Retrospective Cohort Study

• Authors : Wang P; Wang Z; Zhang J

Subjects: hyperbaric oxygen therapy; covid-19; retrospective cohort

• Source: Journal of Multidisciplinary Healthcare, Vol Volume 17, Pp 5501-5511 (2024)

Record details

The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial.

• Authors : Leitman M; Department of Cardiology, Shamir Medical Center, Zerifin, Israel. .; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. .

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Hyperbaric Oxygenation* ; Cardiovascular Diseases*

• Source: Scientific reports [Sci Rep] 2023 Jun 10; Vol. 13 (1), pp. 9473. Date of Electronic Publication: 2023 Jun 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details